Long-term outcomes with initial triple oral therapy in pulmonary arterial hypertension (PAH): Insights from TRITON

The ERS International Congress 2020, Virtual

This annual event brings together the world's respiratory experts to showcase all the latest advances in respiratory medicine and science.

Due to the COVID-19 pandemic, in 2020 the ERS International Congress took place for the first time in a completely virtual format.

Updated assessment and treatment of pulmonary arterial hypertension

Chair(s): M. Hoeper (Hannover, Germany), S. Gaine (Dublin, Ireland)

Session type: Oral Presentation

Long-term outcomes with initial triple oral therapy in pulmonary arterial hypertension (PAH): Insights from TRITON

O. Sitbon (Le Kremlin Bicêtre, France), N. Galiè (Bologna, Italy), M. Doelberg (Allschwil, Switzerland), J. Gibbs (London, United Kingdom), M. Hoeper (Hannover, Germany), M. Stefani (Allschwil, Switzerland), S. Mathai (Baltimore, United States of America), V. Mclaughlin (Ann Arbor, United States of America), L. Perchenet (Allschwil, Switzerland), G. Simonneau (Le Kremlin Bicêtre, France), K. Chin (Dallas, United States of America)

EVENTS HOME

Limited Access

Please log in to myERS to view this content.

Don't have a myERS account? Register

The ERS International Congress 2020, Virtual

Limited Access

#{title}